Evidence map›Paper›PMID 30167096›Full record

ArticleOncotarget2018

Correction: Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers.

Mayuko Furuta, Hiroko Tanaka, Yuichi Shiraishi, Takuro Uchida, Michio Imamura, Akihiro Fujimoto, Masahi Fujita, Aya Sasaki-Oku, Kazuhiro Maejima, Kaoru Nakano and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Mayuko FurutaLaboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Tokyo 108-8639, Japan.
Hiroko TanakaLaboratory of DNA Information Analysis, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Yuichi ShiraishiLaboratory of DNA Information Analysis, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Takuro UchidaDepartment of Gastroenterology and Metabolism, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
Michio ImamuraDepartment of Gastroenterology and Metabolism, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
Akihiro FujimotoLaboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Tokyo 108-8639, Japan.
Masahi FujitaLaboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Tokyo 108-8639, Japan.
Aya Sasaki-OkuLaboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Tokyo 108-8639, Japan.
Kazuhiro MaejimaLaboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Tokyo 108-8639, Japan.
Kaoru NakanoLaboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Tokyo 108-8639, Japan.
Yoshiiku KawakamiDepartment of Gastroenterology and Metabolism, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
Koji ArihiroDepartment of Anatomical Pathology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734- 8551, Japan.
Hiroshi AikataDepartment of Gastroenterology and Metabolism, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
Masaki UenoSecond Department of Surgery, Wakayama Medical University, Wakayama 641-8510, Japan.
Shinya HayamiSecond Department of Surgery, Wakayama Medical University, Wakayama 641-8510, Japan.
Shun-Ichi AriizumiDepartment of Gastroenterological Surgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Masakazu YamamotoDepartment of Gastroenterological Surgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Kunihito GotohDepartment of Surgery, Osaka International Cancer Institute, Osaka 537-8511, Japan.
Hideki OhdanDepartment of Gastroenterological Surgery, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
Hiroki YamaueSecond Department of Surgery, Wakayama Medical University, Wakayama 641-8510, Japan.
Satoru MiyanoLaboratory of DNA Information Analysis, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Kazuaki ChayamaDepartment of Gastroenterology and Metabolism, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
Hidewaki NakagawaLaboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Tokyo 108-8639, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.18632/oncotarget.25308.].

Identifiers

PMID30167096
PMCPMC6114975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.